首页> 外文期刊>Injury >Endovascular management of axillo-subclavian arterial injury: A review of published experience
【24h】

Endovascular management of axillo-subclavian arterial injury: A review of published experience

机译:腋窝锁骨下动脉损伤的血管内治疗:已发表经验的回顾

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The role of endovascular treatment for vascular trauma, including injury to the subclavian and axillary arteries, continues to evolve. Despite growing experience with the utilization of these techniques in the setting of artherosclerotic and aneurysmal disease, published reports in traumatic subclavian and axillary arterial injuries remain confined to sporadic case reports and case series. Methods: We conducted a review of the medical literature from 1990 to 2012 using Pubmed and OVID Medline databases to search for all reports documenting the use of endovascular stenting for the treatment of subclavian or axillary artery injuries. Thirty-two published reports were identified. Individual manuscripts were analysed to abstract data regarding mechanism, location and type of injury, endovascular technique and endograft type utilized, follow-up, and radiographic and clinical outcomes. Results: The use of endovascular stenting for the treatment of subclavian (150) or axillary (10) artery injuries was adequately described for only 160 patients from 1996 to the present. Endovascular treatment was employed after penetrating injury (56.3%; 29 GSW; 61 SW), blunt trauma (21.3%), iatrogenic catheter-related injury (21.8%) and surgical injury (0.6%). Injuries treated included pseudoaneurysm (77), AV fistula (27), occlusion (16), transection (8), perforation (22), dissection (6), or other injuries otherwise not fully described (4). Initial endovascular stent placement was successful in 96.9% of patients. Radiographic and clinical follow-up periods ranging from hospital discharge to 70 months revealed a follow-up patency of 84.4%. No mortalities related to endovascular intervention were reported. New neurologic deficits after the use of endovascular modalities were reported in only one patient. Conclusion: Endovascular treatment of traumatic subclavian and axillary artery injuries continues to evolve. Early results are promising, but experience with this modality and data on late follow-up remain limited. Additional multicenter prospective study and capture of data for these patients is warranted to further define the role of this treatment modality in the setting of trauma.
机译:背景:血管内治疗对血管损伤(包括锁骨下动脉和腋动脉的损伤)的作用在不断发展。尽管在使用这些技术治疗动脉硬化和动脉瘤疾病方面积累了越来越多的经验,但有关锁骨下锁骨和腋动脉损伤的已发表报告仍然仅限于零星的病例报告和病例系列。方法:我们对1990年至2012年的医学文献进行了回顾,使用Pubmed和OVID Medline数据库搜索了所有报道了使用血管内支架治疗锁骨下或腋动脉损伤的报告。确定了三十二份已发表的报告。对单个手稿进行分析,以提取有关机制,损伤的部位和类型,使用的血管内技术和移植物类型,随访以及影像学和临床结果的数据。结果:1996年至今,仅160例患者充分描述了使用血管内支架治疗锁骨下(150)或腋下(10)动脉损伤。穿透性损伤(56.3%; 29 GSW; 61 SW),钝性创伤(21.3%),医源性导管相关性损伤(21.8%)和外科手术损伤(0.6%)之后进行了血管内治疗。治疗的损伤包括假性动脉瘤(77),AV瘘(27),阻塞(16),横断(8),穿孔(22),解剖(6)或其他未完全描述的损伤(4)。最初的血管内支架置入术成功率为96.9%。从出院到70个月的影像学和临床随访期间,随访通畅率为84.4%。没有报道与血管内介入有关的死亡率。仅在一名患者中报告了使用血管内治疗后新的神经功能缺损。结论:锁骨下锁骨和腋动脉损伤的血管内治疗继续发展。早期结果令人鼓舞,但这种方法和后期随访数据的经验仍然有限。有必要对这些患者进行额外的多中心前瞻性研究并收集数据,以进一步确定这种治疗方式在创伤背景中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号